Literature DB >> 28434635

Readmissions, unplanned emergency room visits, and surgical retreatment rates after anti-reflux procedures.

Hsin-Hsiao S Wang1, Rohit Tejwani2, Steven Wolf3, John S Wiener4, Jonathan C Routh4.   

Abstract

INTRODUCTION/
BACKGROUND: The choice between endoscopic injection (EI) and ureteroneocystotomy (UNC) for surgical correction of vesicoureteral reflux (VUR) is controversial.
OBJECTIVE: To compare postoperative outcomes of EI vs UNC. STUDY
DESIGN: This study reviewed linked inpatient (SID), ambulatory surgery (SASD), and emergency department (SEDD) data from five states in the United States (2007-10) to identify pediatric patients with primary VUR undergoing EI or UNC as an initial surgical intervention. Unplanned readmissions, additional procedures, and emergency room (ER) visits were extracted. Statistical analysis was performed using multivariate logistic regression using generalized estimating equation (GEE) to adjust for hospital-level clustering.
RESULTS: The study identified 2556 UNC and 1997 EI procedures. Compared with patients undergoing EI, those who underwent UNC were more likely to be younger (4.6 vs 6.0 years, P < 0.001), male (30 vs 20%, P < 0.001), and publicly insured (34 vs 29%, P < 0.001). As shown in Summary Figure, compared with EI, UNC patients had lower rates of additional anti-reflux procedures within 12 months (25 (1.0) vs 121 (6.1%), P < 0.001), but a higher rate of 30-day and 90-day readmissions and ER visits. On multivariate analysis, patients treated by UNC remained at higher odds of being readmitted (OR = 4.45; 2.69 in 30 days; 90 days, P < 0.001) and to have postoperative ER visits (OR = 3.33; 2.26 in 30 days; 90 days, P < 0.001); however, EI had significantly higher odds of repeat anti-reflux procedures in the subsequent year (OR = 7.12, P < 0.001). DISCUSSIONS: Endoscopic injection constituted nearly half of initial anti-reflux procedures in children. However, patients treated with UNC had significantly lower odds of requiring re-treatment in the first year relative to those treated with EI. By contrast, patients treated with UNC had more than twice the odds of being readmitted or visiting an ER postoperatively. Although the available data were amongst the largest and most well validated, the major limitation was the retrospective nature of the administrative database. The practice setting may not be generalizable to states not included in the analysis.
CONCLUSIONS: Postoperative readmissions and ER visits were uncommon after any surgical intervention for VUR, but were more common among children undergoing UNC. The EI patients had a more than seven-fold increased risk of surgical re-treatment within 1 year.
Copyright © 2017 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Complication; Surgery; Urology; Vesicoureteral reflux

Mesh:

Year:  2017        PMID: 28434635      PMCID: PMC5632086          DOI: 10.1016/j.jpurol.2017.03.016

Source DB:  PubMed          Journal:  J Pediatr Urol        ISSN: 1477-5131            Impact factor:   1.830


  25 in total

1.  The evolution of vesicoureteral reflux management in the era of dextranomer/hyaluronic acid copolymer: a pediatric health information system database study.

Authors:  Thomas S Lendvay; Mathew Sorensen; Charles A Cowan; Byron D Joyner; Michael M Mitchell; Richard W Grady
Journal:  J Urol       Date:  2006-10       Impact factor: 7.450

Review 2.  Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children.

Authors:  Craig A Peters; Steven J Skoog; Billy S Arant; Hillary L Copp; Jack S Elder; R Guy Hudson; Antoine E Khoury; Armando J Lorenzo; Hans G Pohl; Ellen Shapiro; Warren T Snodgrass; Mireya Diaz
Journal:  J Urol       Date:  2010-07-21       Impact factor: 7.450

3.  The demographics and costs of inpatient vesicoureteral reflux management in the USA.

Authors:  John David Spencer; Andrew Schwaderer; Kirk McHugh; Brian Vanderbrink; Brian Becknell; David S Hains
Journal:  Pediatr Nephrol       Date:  2011-05-10       Impact factor: 3.714

4.  The cost-effectiveness of dextranomer/hyaluronic acid copolymer for the management of vesicoureteral reflux. 1: substitution for surgical management.

Authors:  Ronald M Benoit; Pamela B Peele; Steven G Docimo
Journal:  J Urol       Date:  2006-10       Impact factor: 7.450

5.  Vesicoureteral reflux and ureteroceles.

Authors:  Hans G Pohl; Geoffrey F Joyce; Matthew Wise; Bartley G Cilento
Journal:  J Urol       Date:  2007-05       Impact factor: 7.450

6.  Single center experience with endoscopic management of vesicoureteral reflux in children.

Authors:  Jonathan C Routh; David R Vandersteen; Heidi Pfefferle; James J Wolpert; Yuri Reinberg
Journal:  J Urol       Date:  2006-05       Impact factor: 7.450

7.  Is availability of endoscopy changing initial management of vesicoureteral reflux?

Authors:  Caleb P Nelson; Hillary L Copp; Julie Lai; Christopher S Saigal
Journal:  J Urol       Date:  2009-07-22       Impact factor: 7.450

8.  Renal scarring and vesicoureteric reflux.

Authors:  K J Shah; D G Robins; R H White
Journal:  Arch Dis Child       Date:  1978-03       Impact factor: 3.791

Review 9.  Surgical management of vesicoureteral reflux in pediatric patients.

Authors:  Axel Heidenreich; Enver Ozgur; Tanja Becker; Gerald Haupt
Journal:  World J Urol       Date:  2004-06-18       Impact factor: 4.226

10.  Learning from the learning curve: factors associated with successful endoscopic correction of vesicoureteral reflux using dextranomer/hyaluronic acid copolymer.

Authors:  Sumit Dave; Armando J Lorenzo; Antoine E Khoury; Luis H P Braga; Sean J Skeldon; Mohammed Suoub; Walid Farhat; João L Pippi Salle; Darius J Bägli
Journal:  J Urol       Date:  2008-08-16       Impact factor: 7.450

View more
  3 in total

1.  Parental Preferences for Vesicoureteral Reflux Treatment: A Crowd-sourced, Best-worst Scaling Study.

Authors:  Zachary R Dionise; Juan Marcos Gonzalez; Michael L Garcia-Roig; Andrew J Kirsch; Charles D Scales; John S Wiener; J Todd Purves; Jonathan C Routh
Journal:  Urology       Date:  2019-03-14       Impact factor: 2.649

2.  Effects of forced disruption in Medicaid managed care on children with asthma.

Authors:  Katherine Piwnica-Worms; Becky Staiger; Joseph S Ross; Marjorie S Rosenthal; Chima D Ndumele
Journal:  Health Serv Res       Date:  2021-02-23       Impact factor: 3.734

3.  Long-Term Clinical Outcomes and Parental Satisfaction After Dextranomer/Hyaluronic Acid (Dx/HA) Injection for Primary Vesicoureteral Reflux.

Authors:  Michelle Lightfoot; Aylin N Bilgutay; Noah Tollin; Scott Eisenberg; Jake Weiser; Leah Bryan; Edwin Smith; James Elmore; Hal Scherz; Andrew J Kirsch
Journal:  Front Pediatr       Date:  2019-09-27       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.